Unitree Technology: Humanoid robot industry still in early commercialization stage, with investment risk of valuation regression

Unitree Technology issued an "Announcement on Abnormal Fluctuations in Stock Trading," warning that the humanoid robot industry is still in the early commercialization stage, with uncertainty in technology maturity, cultivation of downstream market demand, and industrial chain supporting capabilities. The company's stock closing price rose by a cumulative deviation of more than 30% over three consecutive trading days (October 16, 19, and 20, 2026); as of October 20, its rolling price-to-earnings ratio was 388.25 times, higher than the average level of 39.51 times for the general equipment manufacturing industry over the most recent month.